Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Prof Roberto Orecchia speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the use of radiation therapy in vulvar cancer.
He explains the incidence of this cancer and mentions that the reason for the higher incidence seen in these younger patients may be related to the HPV infection.
Prof Orecchia also describes the different approaches to manage and treat this disease.
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
OncoAlert round up July 28th to August 3rd, 2023
Management of prostate cancer in Africa: Looking to the future
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital